Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma

T cell immunoglobulin and ITIM domain (TIGIT) is a recently identified T cell coinhibitory receptor. Studies have shown that TIGIT is expressed in colon adenocarcinoma, uterine corpus endometrioid carcinoma, breast carcinoma and kidney renal clear cell carcinoma. However, the role of the TIGIT/human...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiangguo, Liu, Juanxi, Cui, Jianjian, Ma, Bin, Zhou, Qiunan, Yang, Xiaojuan, Lu, Zhenhui, Du, Yong, Su, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755146/
https://www.ncbi.nlm.nih.gov/pubmed/31485637
http://dx.doi.org/10.3892/mmr.2019.10641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755146/
https://www.ncbi.nlm.nih.gov/pubmed/31485637
http://dx.doi.org/10.3892/mmr.2019.10641

Ejemplares similares